4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-094755
Sr. VP and CFO acquired 246,146 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rubin Eyal Sr. VP and CFO | 2020-08-11 | Grant or award | +246,146 | 246,146 | I |
Loading xslF345X03/tm2027548d3_4.xml…